Immunogenicity and safety of DTPw-hepatitis B combined vaccines
Singh, O.
Indian Pediatrics 45(10): 815-816
2008
ISSN/ISBN: 0019-6061 PMID: 18948649 Document Number: 623793
Document emailed within 1 workday
Related Documents
Shah, R.; Raghu, M.B.; Shivananda, A.; Mangayarkarasi, S.; Rao, I.; Rao, R.; Bhusari, P.; Joseph, C.A.; Reddy, R. 2008: Immunogenicity and safety of an indigenously developed DTPw hepatitis B combination vaccine in Indian infants Indian Pediatrics 45(10): 819-823Cassidy, W.M.; Jones, G.; Williams, K.; Deforest, A.; Forghani, B.; Virella, G.; Venters, C. 2005: Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 36(3): 187-192
Bulkow, L.R.; McMahon, B.J.; Wainwright, R.B.; Parkinson, A.J.; Wainwright, K.Y.; House, J. 1993: Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults Arctic Medical Research 52(3): 118-126
Zhang, Z.-L.; Wang, X.; Zhu, X.-J.; Zhang, Y.; Liu, Y.; Gao, Z.-G.; Liang, M.; Li, L.; Li, J.-M.; Liu, R.-K.; Dong, X.-J.; Song, G.-X.; Zhang, D.-C.; Wang, W.-Q.; Han, Y.-G.; Chen, J.-T. 2009: Safety and immunogenicity on three lots of influenza split vaccines among adults Zhonghua Liu Xing Bing Xue Za Zhi 30(6): 583-587
Frayha, H.H.; Dent, P.; Shannon, H.S.; Johnson, S.E.; Gordon, L. 1991: Safety and immunogenicity of subcutaneous H. influenzae vaccines in 15-17 month-old children Clinical and Investigative Medicine. Medecine Clinique et Experimentale 14(5): 379-387
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692
Nakalembe, M.; Mirembe, F.M.; Banura, C. 2015: Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy Infectious Agents and Cancer 10: 17
Sabchareon, A.; Lang, J.; Chanthavanich, P.; Yoksan, S.; Forrat, R.; Attanath, P.; Sirivichayakul, C.; Pengsaa, K.; Pojjaroen-Anant, C.; Chambonneau, L.; Saluzzo, J.-F.; Bhamarapravati, N. 2004: Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children Pediatric Infectious Disease Journal 23(2): 99-109
Lee, C.Y.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Dumas, R.; Milcamps, B.; Lin, W. 2000: Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 29-36
Shi, J.; Li, Z.; Zheng, L. 2001: Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine (YDV) on adults Zhonghua Liu Xing Bing Xue Za Zhi 22(2): 105-107
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Schiff, G.M.; Sherwood, J.R.; Zeldis, J.B.; Krause, D.S. 1995: Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 16(1): 12-17
Fu, Q.-p.; He, H.; Li, L.; Chen, H.-p.; Zeng, Y.-x.; Liu, Q.-l.; Fang, G.; Dong, C.-m.; Guo, S.-h.; Li, H.-g.; Wang, H.-y.; He, C.-s.; Zhou, S.-z.; Li, L.; Gu, S.-n.; Zhang, Z.-f.; Dai, M. 2009: The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population Zhonghua Yu Fang Yi Xue Za Zhi 43(10): 903-906
Basu, I.; Supe, P.D.; Agarwal, M. 2020: Comparison of Immunogenicity and Safety between two Quadrivalent Influenza Vaccines in Healthy Indian Adults (18-60 Years) and Elderly (? 61 Years) - a Phase III, Active-Controlled, Randomized Clinical Study Journal of the Association of Physicians of India 68(1): 105
Joshi, N.; Kumar, A.; Raghu, M.B.; Bhave, S.; Arulprakash, R.; Bhusari, P.; Rao, R. 2004: Immunogenicity and safety of hepatitis B vaccine (Shanvac-B) using a novel pre-filled single use injection device Uniject in Indian subjects Indian Journal of Medical Sciences 58(11): 472-477
Ricciardi, G.; Graziano, G. 1990: Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel Bollettino dell'Istituto Sieroterapico Milanese 69(2): 385-390
Petersen, K.; Bulkow, L.; McMahon, B.; Wainwright, R.; Peters, H. 1998: Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants International Journal of Circumpolar Health 57(Suppl 1): 285-292
Huu, T.Ngoc.; Phuong, N.Thi.Minh.; Toan, N.Trong.; Thang, H.Vinh. 2015: Immunogenicity and Safety of Quinvaxem® (Diphtheria, Tetanus, Whole-Cell Pertussis, Hepatitis B and Haemophilus Influenzae Type B Vaccine) Given to Vietnamese Infants at 2 to 4 Months of Age Southeast Asian Journal of Tropical Medicine and Public Health 46(4): 753-763
Sumarokov, A.A.; Lelikov, V.L.; Dzhaparidze, M.N.; Karaeva, L.T.; Derteva, I.I. 1974: Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). II. the cahracterisitcs of choleragen anatoxin immunogenicity compared with corpuscular cholera vaccines administered by syringe and by using a jet injector Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 11: 31-37
Bravo, L.; Carlos, J.; Gatchalian, S.; Borja-Tabora, C.; Bibera, G.; Willems, P.; Safary, A.; Bock, H.L. 1998: The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 772-778